Ono Pharmaceutical Co., Ltd. (TYO:4528)
1,928.50
-12.50 (-0.64%)
Nov 7, 2025, 3:30 PM JST
Ono Pharmaceutical Revenue
Ono Pharmaceutical had revenue of 129.60B JPY in the quarter ending September 30, 2025, with 5.65% growth. This brings the company's revenue in the last twelve months to 503.67B, up 4.00% year-over-year. In the fiscal year ending March 31, 2025, Ono Pharmaceutical had annual revenue of 486.87B, down -3.14%.
Revenue (ttm)
503.67B
Revenue Growth
+4.00%
P/S Ratio
1.80
Revenue / Employee
117.49M
Employees
4,287
Market Cap
906.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 486.87B | -15.80B | -3.14% |
| Mar 31, 2024 | 502.67B | 55.49B | 12.41% |
| Mar 31, 2023 | 447.19B | 85.83B | 23.75% |
| Mar 31, 2022 | 361.36B | 52.08B | 16.84% |
| Mar 31, 2021 | 309.28B | 16.86B | 5.77% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.04T |
| Olympus | 969.02B |
| HOYA Corporation | 892.50B |
Ono Pharmaceutical News
- 8 days ago - Ono Pharmaceutical reports Q2 results - Seeking Alpha
- 4 weeks ago - Ono Announces Encouraging Efficacy Signals of ONO-2808, a S1P5 Receptor Agonist, in an interim analysis of Ongoing Phase 2 Clinical Trial in Patients with Multiple System Atrophy - Benzinga
- 3 months ago - Ono Pharmaceutical Co., Ltd. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 FY2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Vertex and Ono Pharmaceutical form exclusive alliance for Povetacicept in Japan and South Korea - Seeking Alpha
- 4 months ago - Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea - Benzinga
- 4 months ago - Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea - Business Wire
- 6 months ago - Ono Pharmaceutical Co., Ltd. 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha